Home | Welcome to Contract Pharma   
Last Updated Wednesday, July 30 2014
Print

Tris Pharma Appoints New BD VP



Published November 15, 2012
Related Searches: Dosage Development Pharma
Jonathan Berlent has been appointed vice president of business development at Tris Pharma. He will lead the company’s product and technology partnering, and collaborate with branded pharmaceutical companies on their life cycle management opportunities.
 
“As Tris scales up its effort to address the growing unmet need in the industry for liquid extended release technology, Jonathan will lead business development efforts and be our point person with branded pharmaceutical companies,” said Ketan Mehta, president and chief executive officer of Tris Pharma.
 
Mr. Berlent has a combination of pharmaceutical and securities industry experience. For the past nine years, he has held various senior leadership positions in the pharmaceutical industry. Most recently, he was president of Granules USA, where he led its North American operations and successfully launched a finished dosage business platform, working with companies including Pfizer, Novartis, McNeil Consumer Health Janssen, GlaxoSmithKline, Par and Perrigo.


blog comments powered by Disqus
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On